Cargando…
Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach
It is well known that activating mutations in the KRAS and NRAS genes are associated with poor response to anti-EGFR therapies in patients with metastatic colorectal cancer (mCRC). Approximately half of the patients with wild-type (WT) KRAS colorectal carcinoma do not respond to these therapies. Thi...
Autores principales: | del Carmen, Sofía, Sayagués, José María, Bengoechea, Oscar, Anduaga, María Fernanda, Alcazar, Jose Antonio, Gervas, Ruth, García, Jacinto, Orfao, Alberto, Bellvis, Luis Muñoz, Sarasquete, María Eugenia, del Mar Abad, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188146/ https://www.ncbi.nlm.nih.gov/pubmed/30344942 http://dx.doi.org/10.18632/oncotarget.26081 |
Ejemplares similares
-
Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors
por: Gutiérrez, María Laura, et al.
Publicado: (2017) -
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation
por: del Carmen, Sofía, et al.
Publicado: (2020) -
Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients
por: Sayagués, José María, et al.
Publicado: (2018) -
Mapping of Genetic Abnormalities of Primary Tumours from Metastatic CRC by High-Resolution SNP Arrays
por: Sayagués, José María, et al.
Publicado: (2010) -
Genomic characterization of liver metastases from colorectal cancer patients
por: Sayagués, José María, et al.
Publicado: (2016)